NUS
Nu Skin Enterprises, Inc.Company with tickers: NUS
CIK
1021561
CUSIP
67018T105
Shares Outstanding
48,550,543
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $364,490,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Cost of Revenue | — | ||||
| Gross Profit | $246,961,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Operating Expenses | $256,864,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Research & Development | — | ||||
| Operating Income | $-9,903,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Net Income | $107,515,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $2.16 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $2.14 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |